Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base

Article ID	Journal	Published Year	Pages	File Type
8944499	World Neurosurgery	2018	16 Pages	PDF

Abstract

Our findings emphasize the use of denosumab as a neoadjuvant treatment routinely for all cases of skull base GCTs to achieve safe and complete excision of the tumor.

Keywords

RANKL GCT receptor activator of nuclear factor-κB Giant cell tumor Giant cell tumors Denosumab Rank Skull base receptor activator of nuclear factor-κB ligand

Related Topics

Life Sciences Neuroscience Neurology

Preview

Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base

Authors

Arunkumar Sekar, Satish Rudrappa, Swaroop Gopal, Nandita Ghosal, Vinneth Gupta, Lingaraj Ts,